JZP-430 from BOC Sciences

Supplier Page

Supplier Page from
BOC Sciences for
JZP-430

Description

JZP-430, a thiadiazol derivative, has been found to be an ABHD6 inhibitor that could probably be effective in obesity and type II diabetes therapy. IC50: 44 nM